Journal article
Effects of Immunomodulatory and Organism-Associated Molecules on the Permeability of an In Vitro Blood-Brain Barrier Model to Amphotericin B and Fluconazole
Antimicrobial agents and chemotherapy, Vol.54(3), pp.1305-1310
03/01/2010
DOI: 10.1128/AAC.01263-09
PMCID: PMC2825964
PMID: 19995929
Abstract
Amphotericin B (AMB) is used to treat fungal infections of the central nervous system (CNS). However, AMB shows poor penetration into the CNS and little is known about the factors affecting its permeation through the blood-brain barrier (BBB). Therefore, we studied immunomodulatory and organism-associated molecules affecting the permeability of an in vitro BBB model to AMB. We examined the effects of interleukin-1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), lipoteichoic acid (LTA), zymosan (ZYM), dexamethasone (DEX), cyclosporine, and tacrolimus on transendothelial electrical resistance (TEER); endothelial tight junctions; filamentous actin; and permeability to deoxycholate AMB (DAMB), liposomal AMB (LAMB), and fluconazole. Proinflammatory cytokines and organism-associated molecules significantly decreased the mean TEER by 40.7 to 100% (P ≤ 0.004). DEX increased the mean TEER by 18.2 to 26.4% (P ≤ 0.04). TNF-α and LPS increased the permeability to AMB by 8.2 to 14.5% compared to that for the controls (1.1 to 2.4%) (P ≤ 0.04). None of the other molecules affected the model's permeability to AMB. By comparison, the BBB model's permeability to fluconazole was >78% under all conditions studied, without significant differences between the controls and the experimental groups. LPS and TNF-α decreased tight-junction protein zona occludens 1 (ZO-1) between endothelial cells. In conclusion, IL-1β, ZYM, and LTA increased the permeability of the BBB to small ions but not to AMB, whereas TNF-α and LPS, which disrupted the endothelial layer integrity, increased the permeability to AMB.
Details
- Title: Subtitle
- Effects of Immunomodulatory and Organism-Associated Molecules on the Permeability of an In Vitro Blood-Brain Barrier Model to Amphotericin B and Fluconazole
- Creators
- Vasilios Pyrgos - National Cancer InstituteDiane Mickiene - National Cancer InstituteTin Sein - National Cancer InstituteMargaret Cotton - National Cancer InstituteAndrea Fransesconi - National Cancer InstituteIsaac Mizrahi - MedStar Washington Hospital CenterMartha Donoghue - National Cancer InstituteNikkida Bundrant - National Cancer InstituteSu-Young Kim - National Cancer InstituteMatthew Hardwick - MedStar Washington Hospital CenterShmuel Shoham - MedStar Washington Hospital CenterThomas J Walsh - National Cancer Institute
- Resource Type
- Journal article
- Publication Details
- Antimicrobial agents and chemotherapy, Vol.54(3), pp.1305-1310
- DOI
- 10.1128/AAC.01263-09
- PMID
- 19995929
- PMCID
- PMC2825964
- NLM abbreviation
- Antimicrob Agents Chemother
- ISSN
- 0066-4804
- eISSN
- 1098-6596
- Publisher
- American Society for Microbiology
- Number of pages
- 6
- Language
- English
- Date published
- 03/01/2010
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984949463802771
Metrics
4 Record Views